when will oral semaglutide be available Here's Novo Nordisk's First Obesity Drug In Europe With Proven Heart Health Impact FDA Approves Oral Semaglutide as
Description
Clinical trials show that semaglutide users who make no intentional food changes lose an average of 10-15% of body weight over 68 weeks
The researchers expressed concern that this pattern could ultimately compromise patients' metabolic health, healthspan, and longevity
Although Ozempic contains the same active ingredient as some weight loss medications, it is only authorized for managing type 2 diabetes and not for weight loss
Jennifer L
